NEW ORLEANS — Patients with dry eye disease saw improvements in symptoms and signs after treatment with varenicline nasal spray, according to a study presented at the American Academy of Ophthalmology meeting. Marjan Farid, MD, said Tyrvaya (varenicline solution, Oyster Point Pharma), formerly known as OC-01, is a cholinergic agonist that leads to an increase in basal tear production